Form 8-K Alkermes plc. For: Oct 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Alkermes (ALKS) PT Lowered to $30 at Goldman Sachs
October 25, 2024 5:43 AM EDTGoldman Sachs analyst Chris Shibutani lowered the price target on Alkermes (NASDAQ: ALKS) to $30.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "ALKS 3Q24 results included operating results for the quarter from the current commercial portfolio that included some puts and... More
Alkermes (ALKS) PT Lowered to $25 at Stifel
October 24, 2024 10:56 AM EDTStifel analyst Paul Matteis lowered the price target on Alkermes (NASDAQ: ALKS) to $25.00 (from $28.00) while maintaining a Hold rating.
The analyst comments "Alkermes 3Q was overall mixed: product revenues were in-line, royalty revenues (less important) missed, and earnings came in just a... More
